Glucose monitoring specialist Dexcom is increasing its partnership with health-tracking ring maker Oura to supply Stelo customers and ring wearers with metabolic well being options, together with meal insights and glucose information.
Stelo supplies people 18 and up who don’t require insulin with round the clock glucose readings and delivers customized insights into glucose well being, providing customers actionable data to make knowledgeable selections. The patch aids in detecting regular (euglycemic) and low or excessive (dysglycemic) glucose ranges.
By way of the partnership, customers of Dexcom’s steady glucose monitor Stelo, which acquired FDA clearance in March of final yr, can have entry to Meal and Glucose.
By way of Meal, wearers can take an image of their meals via the Oura app, and AI-enabled meals recognition and diet evaluation will likely be used to supply customers with insights on how their meals or snacks have an effect on them all through the day. Meals focuses on the macronutrients in meals versus energy. The aim is for Oura ring wearers to know higher how their meals impacts their well being.
The Oura app additionally supplies customers with suggestions on how you can curate their meals to “keep away from power slumps and cravings.”
Glucose will present ring-wearers with contextual graphs and insights to assist them perceive the connection between meals, every day motion, glucose ranges, stress and tags via data collected via the Stelo gadget.
Customers may also be taught habits that can assist them keep or obtain optimum glucose ranges, and acquire entry to “Time Above Vary,” which tracks when glucose ranges are above a goal vary and supplies AI-enabled evaluation of a member’s glucose tendencies.
By way of the partnership with Dexcom, customers should purchase a Stelo CGM via the Oura web site and entry Meal and Glucose by way of the Oura app.
“Our product roadmap for this yr is constructed on a strong funding in AI-forward choices that allow a deeper understanding of the dynamic interaction of key well being elements,” Holly Shelton, Oura’s chief product officer, mentioned in an announcement.
“The addition of nutrition-focused options to our product expertise was a pure subsequent step, particularly contemplating how private food regimen—and its affect on well being—will be. Our our bodies all course of meals in several methods, which is why we’re leveraging a novel mixture of Oura’s in depth biometric monitoring, generative AI and Stelo glucose information to handle a crucial want for extra individualized and accessible metabolic well being options.”
THE LARGER TREND
In November, Dexcom made a $75 million funding in Oura and established a strategic partnership to allow two-way information movement between Dexcom’s CGM and the Oura Ring.
A month later, Oura closed a $200 million Sequence D funding spherical, bringing the corporate’s valuation to $5.2 billion.
In 2021, Oura scored $100 million in a Sequence C spherical. A yr later, the corporate introduced it reached a valuation of $2.55 billion. Oura garnered $28 million in Sequence B funding in 2020.
The corporate has acquired three firms prior to now few years: information firm Sparta Science, customized metabolic well being firm Veri and digital identification startup Proxy.
In March, Oura introduced it had appointed its first chief medical officer, Dr. Ricky Bloomfield. Earlier than Oura, Bloomfield served as scientific and well being informatics lead at Apple Well being, overseeing the launch of a number of options, together with Apple’s Well being Information on the iPhone.
